Apoptosis, a form of altruistic suicide, is activated physiologically in embryonic development and also in response to environmental stresses such as pathogens and radiation (30, 33, 52, 60, 63) . Recently it has become clear that apoptosis is the predominant mechanism by which cancer chemotherapeutic agents kill cells (18, 63) . Apoptosis is generally defined cytologically by violent membrane blebbing, cytoplasmic fragmentation, nuclear condensation and pycnosis, and DNA degradation into oligonucleosome-size fragments (8, 30) . A great deal of recent progress has been made in elucidating the components of proapoptotic pathways, such as those initiated by tumor necrosis factor alpha (TNF-␣), Fas ligand, and ceramide (10, 40, 43, 52, 55, 66) . These pathways are characterized by a cascade of proteases related to interleukin-converting enzyme (ICE), which are activated by proteolytic cleavage (6, 21, 34, 38) . However, apoptosis is a closely regulated process, and much less is known about the signalling mechanisms used by survival factors which inhibit the commitment to apoptosis.
Insulin-like growth factor I (IGF-I) is a major survival factor in serum and is able to protect cells from apoptosis under a wide variety of circumstances, including growth factor withdrawal in hematopoietic cells (37) , overexpression of myc (22) or of ICE protease (26) in fibroblasts, chemotherapy (54) , and, as we show here, irradiation with UV-B. IGF-I elicits its responses through interaction with and activation of the IGF-I receptor. As is the case with other receptor tyrosine kinases, the IGF-I receptor autophosphorylates in response to ligand, which activates its kinase activity (15, 65) . Receptor activation, in turn, results in phosphorylation of insulin receptor substrate 1 and activation of cascades of kinases which include phosphatidylinositol 3-kinase (PI3 kinase), p70 S6 kinase, and mitogenactivated protein (MAP) kinase (15) .
The goal of the work described here was to elucidate the signal transduction pathways used by the IGF-I receptor to protect cells from apoptosis. We found that the kinase activity of the IGF-I receptor was necessary for antiapoptotic protection and that the epidermal growth factor (EGF) receptor was not protective unless overexpressed. Activation of PI3 kinase and its putative effector Akt/PKB was sufficient for protection, but in contrast with other reports (58, 66, 67) , activation of MAP kinase, p38/HOG1, and p70 S6 kinase did not correlate with the regulation of apoptosis in this system.
FIG. 1. UV-B induces apoptosis in fibroblasts. (A)
Time-lapse videomicroscopy of rat fibroblasts treated with UV-B. Cells were irradiated and monitored for 18 h as described in Materials and Methods. Arrows point to a cell undergoing apoptosis. Numbers indicate time after treatment with UV. (B) Nuclear fragmentation in fibroblasts stained with propidium iodide. Top row, nuclear morphology; bottom row, FACS profiles (cells collected 15 h after treatment with UV and stained with propidium iodide). (C) DNA fragmentation in irradiated cells assessed by TUNEL. Cells were fixed 8 h after UV treatment, and apoptosis was assessed with the TUNEL kit and propidium iodide. Cells were not treated with RNase before fixation, and therefore nuclei and cytoplasm display a red color after propidium iodide staining. Magnification is indicated. (D) Time course of DNA laddering in fibroblasts after UV irradiation. DNA was extracted from the cytoplasm of irradiated cells at the indicated time points after treatment as described. M, molecular weight markers (X174 replicative-form DNA HaeIII digest).
phorylation site [CTGFLT(p)EY(p)VATR] conjugated to keyhole limpet hemocyanin (Pierce, Rockford, Ill.) and affinity purified negatively against the unphosphorylated peptide and positively against the phosphopeptide.
EGF, phorbol myristate acetate insulin, thrombin, cycloheximide, and wortmannin were from Sigma, St. Louis, Mo. IGF-I was a gift from Thomas Sturgill, and rapamycin was from Calbiochem, La Jolla, Calif.
Enzyme assays. Protein kinase assays and protein analysis were performed as described elsewhere (50) .
UV irradiation. Cells were plated at 8 ϫ 10 5 /10-cm-diameter or 3 ϫ 10 5 /6-cm-diameter tissue culture dish in antibiotic-free Dulbecco modified Eagle medium (DMEM) plus 10% fetal calf serum. After 12 h, cultures were changed to serum-free medium; after an additional 12 h, cultures were placed on a transilluminator equipped with a filter specific for UV-B. The transilluminator was calibrated with a UV-B-sensitive photometer. After treatment with UV (780 J/m 2 ) for 1 min, unless otherwise indicated, fresh serum-free medium, supplemented with growth factors if required, was added to the cells.
Apoptosis assays. Time-lapse videomicroscopy of UV-irradiated cells was started immediately after irradiation and was continued for 18 h. Cells were kept on a heating platform at 37ЊC in L-15 medium (Gibco) instead of DMEM so as to provide better pH control.
For analysis of DNA fragmentation, cytosolic DNA was isolated by solubilizing 5 ϫ 10 5 cells in 20 mM Tris-HCl (pH 7.4)-50 mM EDTA-0.2% Nonidet P-40 (NP-40). After centrifugation (15 min, 15 times at 10 3 rpm), supernatants were transferred to fresh microcentrifuge tubes and proteins were digested overnight with proteinase K (0.1 mg/ml), extracted with phenol-chloroform, and precipitated by ammonium acetate at a final concentration of 2.5 M. The pellet was washed with 70% ethanol, resuspended in 15 l of Tris-EDTA containing 1 mg of RNase A per ml, and after incubation for 1 h at 37ЊC analyzed by electrophoresis in 2% agarose followed by ethidium bromide staining.
On the single-cell level, DNA fragmentation was visualized by incorporation of fluorescent oligonucleotides by terminal deoxynucleotidyltransferase with a TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling) kit (Boehringer Mannheim). Cells were grown on glass coverslips coated with collagen, and detection of apoptosis was performed as instructed by the manufacturer, 8 h after UV irradiation.
Quantitation of apoptosis was performed by fluorescence-activated cell sorting (FACS) analysis. Cells were pelleted by centrifugation (200 ϫ g, 10 min) and resuspended in 300 l of propidium iodide solution containing 0.1% sodium citrate, 0.3% NP-40, 100 g of RNase A per ml, and 50 g of propidium iodide per ml. FACS analysis was performed with a Becton Dickinson FACScan. The left edge of the control cell profile was taken as the border separating normal, diploid cells (to the right) from apoptotic, hypodiploid cells (to the left). The percentage of apoptotic cells was calculated as a ratio between events on the left side and on the right side of the border. Results presented in the figures were obtained in one representative experiment with at least two independently analyzed dishes for each value. Error bars indicate range or standard deviation. Qualitatively similar results were obtained in at least three independent experiments unless otherwise indicated. To determine statistical significance, data were normalized to set UV-induced apoptosis at 100%, and the data from several experiments (at least three) were pooled.
Apoptosis following transient expression was determined by the TUNEL assay. Vectors encoding constitutively active or kinase-deficient PI3 kinase containing the c-Myc epitope tag (20) or Akt containing the HA tag were transfected into Cos-7 cells by electroporation (250 V, 250 F, 10 g/ml). At 24 h after transfection, cells were placed in serum-free medium for 12 h and irradiated with UV-B as described above. Eight hours later, cells were fixed with 4% paraformaldehyde-0.2% acrolein-0.2% NP-40 for 20 min and stained with antibodies to c-Myc or HA followed by goat anti-mouse antibodies labeled with Texas red. Then apoptotic cells were revealed by fluorescein-labeled oligonucleotides (TUNEL kit) as described above. Cells were inspected by fluorescence microscopy, and the frequency of apoptosis was scored by counting a minimum of 300 cells positive for c-Myc or HA epitope staining.
RESULTS

Irradiation of Rat-1 fibroblasts by UV-B induces apoptosis.
Analysis of antiapoptotic signalling by the IGF-I receptor required the establishment of a rapid, reliable method of inducing apoptosis in fibroblast cell lines. Rat-1 cells proved to be resistant to apoptosis induced by TNF-␣, H 2 O 2 , or ceramides, although these agents induced dramatic early morphological changes (data not shown). By contrast, irradiation of these cells with UV-B reproducibly and robustly induced apoptosis, which was morphologically visible within 6 h and maximal at 12 to 18 h.
Time-lapse video recording of Rat-1 fibroblasts irradiated with UV-B revealed extensive membrane blebbing, loss of contacts with neighboring cells, shrinking of the cytoplasm and disintegration into small vesicles, and ultimately detachment of cells from the culture dish (Fig. 1A) . Staining of the detached cells with propidium iodide showed condensation of chromatin and disintegration of nuclei into small vesicles (Fig. 1B) . These changes in morphology coincided with the DNA fragmentation which is a specific manifestation of apoptosis. Figure 1C and D show DNA fragmentation assessed by TUNEL labeling and by agarose gel electrophoresis, respectively. The TUNEL assay gave positive signals on UV-treated but not control cells (Fig.  1C) . On higher magnification, fragmentation of positively stained nuclei could be observed. Small DNA fragments appeared in preparations of cytoplasmic DNA from fibroblasts 6 h after UV treatment (Fig. 1D ). Apoptosis could be induced by UV and inhibited by IGF-I (see below) even in the presence of cycloheximide (data not shown), indicating that the entire process was regulated posttranslationally, as previously described (22) .
The extent of apoptosis can conveniently be quantified by FACS analysis of cells stained with propidium iodide. The fluorescence profile of detached cells showed a significant shift After irradiation cells were supplemented with 100 ng of IGF-I or EGF per ml or 1 U of thrombin per ml in serum-free DMEM. The result of a single representative experiment with three independent plates analyzed for each value is shown. Statistical analysis using pooled data from three independent experiments shows that the difference between UV and UV plus IGF-I is significant (P Ͻ 0.0001) but the difference between UV and UV plus EGF is not (P Ͼ 0.28). Contr, control.
to the left ( IGF-I specifically protects fibroblasts from UV-induced apoptosis. IGF-I reduced the sensitivity of Rat-1 fibroblasts to UV-induced apoptosis in a dose-dependent fashion, with maximum protection occurring around 1 g/ml (200 nM) ( Fig.  2A) . The fact that superphysiological concentrations of IGF-I provide the maximum protection may reflect a requirement for continuous exposure of cells to this agonist during the period prior to commitment to apoptosis, but this has not been explicitly tested. For subsequent experiments, we chose to use a suboptimal concentration of 100 ng of IGF-I per ml so as best to detect effects of agents which might enhance or inhibit the antiapoptotic actions of IGF-I. This degree of protection (30 to 50%) is comparable to that previously observed by Harrington et al. in their studies on the effects of IGF-I on myc-induced apoptosis (22) .
The antiapoptotic effects of IGF-I were specific to this agonist, since neither EGF nor thrombin was able to confer protection for Rat-1 cells against UV-induced apoptosis (Fig. 2B ) even at superphysiological concentrations (data not shown). On the other hand, all of these agonists were able to induce activation of MAP kinase (see Fig. 5 ; also data not shown), indicating that the cells expressed functional receptors.
Kinase activity of the IGF-I receptor is necessary for protection from apoptosis. In Rat-1 fibroblasts overexpressing wild-type IGF-I receptors (RIG cells) (46) , the antiapoptotic effect of IGF-I was enhanced compared to parental Rat-1 cells; equivalent protection was achieved at IGF-I concentrations at least 10 times lower than required in Rat-1 cells or Rat-1/neo cells transfected with empty vector, and maximal protection was nearly complete (Fig. 3) . In contrast, IGF-I did not induce protection in cells overexpressing IGF-I receptors with impaired kinase activity.
Overexpression of an IGF-I receptor with a mutation in the ATP binding loop (K1003A) completely blocked IGF-I-mediated protection, and indeed this mutant functioned as a dominant negative, sensitizing cells to apoptosis (Fig. 4 , RKϪ cells). Note that overexpression of the wild-type receptor also modestly, but reproducibly, sensitized cells to UV-induced apoptosis under IGF-I-free conditions relative to parental Rat-1 cells.
Antiapoptotic signalling pathways downstream from the IGF-I receptor. We first considered the possible role of MAP kinase (ERK2) in IGF-I-mediated protection from apoptosis because of reports that activation of this kinase could be antiapoptotic (14, 67) . We were able to determine that activation of MAP kinase is insufficient for antiapoptotic protection, because EGF, which is not protective, induced an activation of MAP kinase which was even more substantial and persistent than that induced by IGF-I (Fig. 5A to C). We were also able to determine that activation of MAP kinase is not necessary for antiapoptotic protection by using PD98059, which is a specific inhibitor of the activation of MEK (MAP kinase kinase) (2) . This agent effectively inhibited the in vivo activation of MAP kinase in response to IGF-I or EGF, inhibited EGF-induced entry of Rat-1 cells into S phase (Fig. 5D ), but had no effect on the ability of IGF-I to protect against UV-induced apoptosis, even when IGF-I was used at suboptimal concentrations (Fig.  6A) . In IGF-I-treated cells, maximal activation of MAP kinase was about 40% of the EGF-induced activity, and preincubation with PD98059 decreased it below the basal level in unstimulated cells (Fig. 5C ). These data indicate that MAP kinase activity is neither necessary nor sufficient for antiapoptotic signalling by IGF-I.
The so-called stress kinase pathway has been postulated to be important in regulating apoptosis (14, 25, 66, 67) , and so we examined the activating phosphorylation of one member of this pathway, p38/HOG1. We found that both UV and EGF were able to activate p38 phosphorylation in this system and that IGF-I had no detectable effect on the p38 activation induced by UV (Fig. 5E) . Thus, our data indicate that activation of this stress kinase is unrelated to the regulation of apoptosis in UV-treated Rat-1 cells.
PI3 kinase is an important component of signal transduction by insulin family receptors (15, 35, 39, 62) . To examine the involvement of PI3 kinase in IGF-I-mediated protection, we preincubated cells for 15 min with wortmannin, an inhibitor of PI3 kinase, and then added IGF-I. In contrast to the MEK inhibitor PD98059, wortmannin completely blocked the protective effect of IGF-I at a concentration of 4 nM (Fig. 6B) , which is in the 50% inhibitory concentration range reported in vitro for inhibition of PI3 kinase (13, 64) . Note that in the absence of UV treatment, wortmannin did not by itself induce apoptosis (Fig. 6B) . P70 S6 kinase is believed to lie downstream from PI3 kinase, and its activation is inhibited by rapamycin (11). However, rapamycin did not interfere with protection provided by IGF-I (Fig. 6A) , although it blocked activation of p70 S6 kinase activation as measured by gel mobility shift (data not shown). Note that rapamycin and PD98059 did not have any effect on protection even when IGF-I was used at a suboptimal concentration (100 ng/ml). In contrast, 4 nM wortmannin ablated protection even when induced by the maximally effective concentration of IGF-I (1 g/ml).
Other tyrosine kinases become antiapoptotic when overexpressed. Although antiapoptotic signalling appeared to be a specific property of the IGF-I receptor, it has been shown that overexpression of tyrosine kinases such as the EGF receptor and pp60
v-src may activate PI3 kinase (20, 48, 56, 57) . Therefore, we considered the possibility that overexpression could allow these other tyrosine kinases to activate the protective pathway. Indeed, overexpression of the EGF receptor allowed EGF to effectively protect Rat-1 fibroblasts against UV-induced apoptosis (Fig. 7A) . Similarly, overexpression of a temperature-conditional variant of pp60 v-src (45) rendered Rat-1 cells resistant to UV-induced apoptosis at the permissive temperature (34ЊC) but not at a more restrictive temperature (38ЊC) (Fig. 7B) . Antiapoptotic signalling by the EGF receptor or by pp60 v-src was blocked by wortmannin, indicating the necessity for PI3 kinase activity.
Activation of PI3 kinase is sufficient for protection. Because antiapoptotic signalling was blocked by wortmannin, we examined whether the putative wortmannin target, PI3 kinase, was sufficient to inhibit UV-induced apoptosis. Cells were transiently transfected with constructs encoding mutant forms of PI3 kinase which were either kinase dead or constitutively active. At 24 h after transfection, the cells were treated with UV and 6 or 8 h later were assayed for expression of PI3 kinase by immunofluorescence (red cells) or apoptosis with the TUNEL assay (green cells) as described in Materials and Methods. It can be seen that many cells expressing the kinasedefective PI3 kinase underwent apoptosis and displayed both red and green staining (Fig. 8A) . By contrast, many fewer cells expressing the constitutively active PI3 kinase underwent apoptosis, and thus the apoptotic cells which stained green tended to be those which did not express the construct and consequently did not stain red (Fig. 8B) . Antiapoptotic protection was quantified by counting at least 300 cells expressing the PI3 kinase mutants, which revealed that expression of constitutively active PI3 kinase reduced apoptosis two-to threefold (Fig. 8C ). This level of protection is comparable in magnitude to that achieved for Rat-1 cells with the maximal dose of IGF-I (Fig. 3B) . Protection provided by the constitutively active PI3 kinase was blocked by wortmannin.
Activation of Akt is sufficient for protection. The serine/ threonine protein kinase Akt is hypothesized to be one of the effectors for PI3 kinase signalling (7, 19, 31) . Therefore, we wished to determine whether activated Akt could also protect against apoptosis. The data in Fig. 9 demonstrate that Akt activated by targeting to the membrane by myristoylation was able to protect against UV-induced apoptosis (Fig. 9B) , whereas kinase-dead Akt was not (Fig. 9A) ; cells expressing kinase-defective Akt frequently underwent apoptosis (cells costaining red and green), whereas cells expressing myristoylated Akt were resistant to apoptosis (red and green cells tended to be in two mutually exclusive populations). The extent of apoptosis was quantified by counting cells microscopically, and these data are summarized in Fig. 9D . The myristoylated Akt displayed enhanced kinase activity relative to the wild-type unmyristoylated protein, measured with histone H2B as the substrate (Fig. 9C) .
DISCUSSION
IGF-I is a major cellular survival factor, protecting cells from apoptosis induced by a wide variety of agents, including growth factor withdrawal (4, 51), etoposide (54), oncogene overexpression (22) , and overexpression of ICE-related protease (26) . Thus, it is very likely that signals from the IGF-I receptor act on a step in the apoptotic process shared by all of these proapoptotic agonists. In the work reported here, we analyzed We used fibroblasts irradiated with UV-B as a model system for analyzing antiapoptotic signalling. The advantages of this system include the fact that the cells grow well, are readily transfected, and are rapidly and robustly induced to undergo apoptosis upon treatment with UV-B. Importantly, the apoptosis induced by UV and a substantial portion of the IGF-Iinduced protection occur even in the presence of cycloheximide. This finding indicates that the entire process can be regulated posttranslationally, thus simplifying mechanistic analysis by removing confounding effects due to secondary changes in gene expression.
Antiapoptotic signalling is preferentially a property of the IGF-I receptor. We found that IGF-I could protect Rat-1 cells from apoptosis but that antiapoptotic signalling was not evident in response to EGF or thrombin even at high concentrations. This result implies that the IGF-I receptor displays an unusual signalling capacity not ordinarily shared by at least these other receptors, in agreement with the report of Harrington et al. (22) . However, when the EGF receptor was overexpressed, it became capable of conferring protection from apoptosis. This result suggests that the overexpressed receptor was able to engage significant activity from a signalling pathway with which it normally interacts only slightly. Consistent with this idea, we found that wortmannin inhibited protection by endogenous IGF-I receptors and by overexpressed EGF receptors, in agreement with earlier reports indicating that the EGF receptor stimulated phosphatidylinositol turnover in cells expressing high levels of this receptor (54-57). We do not know whether activation of PI3 kinase occurs directly by the overexpressed EGF receptor or by activation of ErbB3 (57) . Comparable results were obtained with cells expressing pp60 v-src . These findings are of significance for cancer therapy, since it is now widely suspected that both chemotherapy and radiation kill cancer cells predominantly by inducing apoptosis (18, 30, 63) . Autocrine loops involving the IGF-I receptor have been described in many cancers (27, 28, 42, 49, 59) , and it is likely that these cells will display resistance to therapy, as suggested by Baserga and colleagues (49a, 54) . However, an even larger number of malignancies overexpress other receptors (such as members of the EGF receptor family) and nonreceptor tyrosine kinases (1, 16) . The expression of these kinases, receptors, and cognate growth factors may be of importance not only for stimulating unregulated growth of the tumors but also for decreasing their sensitivity to therapy-induced apoptosis.
Tyrosine kinase activity is essential for antiapoptotic signalling. As with most signalling activities by tyrosine kinase receptors, antiapoptotic signalling by the IGF-I receptor is dependent on the kinase activity of the receptor (15, 65) . A mutant rendered kinase defective by mutation in the ATP binding domain (K1003A) functioned as a classic dominant negative. Cells expressing this mutant receptor were more sensitive to apoptosis than cells expressing wild-type receptor or parental cells. It is possible that this kinase-defective receptor titrates out endogenous IGF-I receptors and/or downstream signalling molecules. Addition of IGF-I to cells expressing this mutant receptor did not protect the cells from apoptosis (indeed, there may have been a small sensitization to apoptosis). Surprisingly, however, an IGF-I receptor mutant rendered kinase defective by mutation of the major intrakinase sites of tyrosine phosphorylation (Y1131,1135,1136F) was not an effective dominant negative (data not shown). Expression of this mutant receptor also did not confer protection, but the antiapoptotic properties of endogenous IGF-I receptors were not compromised.
It is not known why one mutant receptor functions as a dominant negative while the other does not. Both mutant receptors are kinase dead in vitro and in vivo, are unable to stimulate mitogenesis, and are expressed on the cell surface in comparable amounts, as determined by FACS analysis with anti-human IGF-I receptor antibodies (46, 47) . Analogous results have also been seen for the related insulin receptor, where a kinase-defective ATP binding loop mutant functioned as a dominant negative whereas a kinase-defective autophosphorylation loop mutant was neutral for signalling (62) . It is possible that this functional difference reflects differences in the abilities of the receptors to oligomerize with endogenous receptors or with signalling molecules important for regulating apoptosis.
Signalling pathways downstream of the IGF-I receptor. A major effector for signalling by the insulin and IGF-I receptors is PI3 kinase (9, 15, 35, 39) . This enzyme consists of a 110-kDa catalytic subunit and an 85-kDa regulatory subunit. Activation of the PI3 kinase activity ordinarily involves binding via an SH2 domain on the p85 subunit to tyrosine phosphorylated residues on insulin receptor substrate 1, recruitment of the PI3 kinase to the membrane (the site of its lipid or protein substrates), and in some cases tyrosine phosphorylation of the 110-kDa catalytic subunit and/or 85-kDa subunit (29) . The activated enzyme generates 3Ј phosphorylated inositol derivatives which are thought to function as second messengers. The 110-kDa subunit also is reported to display a protein kinase activity, but the physiologic significance of this is unclear (9, 70) .
We have found that the ability of IGF-I to protect cells from apoptosis is blocked by wortmannin, which is an inhibitor of PI3 kinase activity. This finding is in agreement with several other reports of wortmannin-sensitive protection from apoptosis (36, 68, 69) . Wortmannin is widely used as a PI3 kinase inhibitor, although it also is reported to inhibit other enzymes involved in cell regulation, including DNA-dependent protein kinase, PI4 kinase, and phospholipase A2 (13, 23, 41, 64) . However, inhibition of most of these enzymes requires higher concentrations of wortmannin than were effective at blocking apoptotic protection (4 nM). The fact that 4 nM wortmannin FIG. 5 . Activation of MAP kinase in Rat-1 cells. Rat-1 fibroblasts were incubated for 15 h in serum-free DMEM and stimulated with 100 ng EGF or IGF-I per ml for the indicated time. PD98059 (50 M) or wortmannin (1 M) was added 15 min prior to stimulation. Kinase assays were performed as described previously (43) . Components of the reaction were separated on a sodium dodecyl sulfate-15% polyacrylamide gel and transferred to nitrocellulose. (A) Loading control. Equivalence of MAP kinase in each reaction mixture was verified by probing the membrane with antibodies to ERK2, followed by enhanced chemiluminescence detection. (B) MBP phosphorylation. Shown is an autoradiograph of the same membrane. (C) Quantitation of kinase activity. Nitrocellulose strips at the M r of the substrate myelin basic protein were cut from the membrane, and radioactivity was determined by scintillation spectrometry. (D) PD98059 inhibits EGF-stimulated progression through the cell cycle. Cells were stained with propidium iodide and analyzed by FACS 15 h after stimulation with 100 ng of EGF per ml. PD98059 dissolved in dimethyl sulfoxide or dimethyl sulfoxide alone was added 15 min before EGF. (E) Effect of UV-B, IGF-I, and EGF on MAP kinase and p38 phosphorylation. Cells were left intact (lane 1), irradiated with UV-B at 78 J/m 2 (lane 2) or 780 J/m 2 (lanes 3 to 5), or stimulated with IGF-I (lanes 5 to 7) or EGF (lanes 8 and 9) and lysed 15 min after treatment. In lane 5, cells were stimulated with IGF-I 1 min before irradiation with UV. In lanes 4, 7, and 9 cells were treated with 50 M PD98059. Cell lysates containing 30 g of protein were separated on a sodium dodecyl sulfate-7% polyacrylamide gel, transferred to nitrocellulose, and analyzed with antibodies to phospho-p38. The membrane was then stripped and reprobed with antibodies to phospho-MAP kinase.
was effective at blocking antiapoptotic signalling and that this concentration is close to the 50% inhibitory concentration for in vitro inhibition of PI3 kinase (13, 64) suggests that PI3 kinase is the most likely target for wortmannin in the regulation of apoptosis.
To confirm the role of PI3 kinase in apoptosis, and to determine whether this enzyme was sufficient for protection, we made use of a constitutively activated mutant form of the enzyme, in which a truncated p85 subunit was linked to the catalytic subunit (24) . This activated form was expressed by transient transfection in Cos-7 cells, and the effects on UVinduced apoptosis were monitored. Apoptosis was reduced two-to threefold in cells expressing the activated PI3 kinase compared to control cells. This is very close to the maximum level of protection provided by IGF-I treatment of Rat-1 fibroblasts. The effect of the activated PI3 kinase was also wortmannin sensitive: in the presence of the inhibitor, no differences were found between the frequency of apoptosis in cells expressing active and inactive PI3 kinase. Thus, activation of PI3 kinase is both necessary and sufficient for protecting cells against apoptosis in this system.
The serine/threonine kinase Akt has been described as a downstream effector of PI3 kinase (7, 19, 31) , and thus it was important to determine whether this enzyme could substitute for activated PI3 kinase in antiapoptotic signalling. Using an experimental paradigm identical to the one which revealed the antiapoptotic effects of PI3 kinase, we transfected an expression construct encoding an Akt which had been activated by N-terminal myristoylation into Cos-7 cells and examined their sensitivity to UV-induced apoptosis. Expression of the activated Akt conferred protection against apoptosis whereas the kinase-dead Akt did not, consistent with the idea that Akt is a target of PI3 kinase in antiapoptotic signalling. The p70 S6 kinase lies downstream of Akt (7), but we demonstrate that inhibiting the activation of this enzyme with rapamycin does not block antiapoptotic signalling. This result indicates that the antiapoptotic target of Akt is upstream of p70 S6 kinase, in agreement with the results of Yao and Cooper (69) .
It was surprising to find that expression of activated PI3 kinase or Akt was sufficient to protect cells from apoptosis. However, it is important to realize that cells transfected with these constructs expressed very high levels of the enzymes. It is possible that under conditions of overexpression, a single sig- nalling molecule can perform a function which under more physiological conditions is carried out by a consortium of signals. Thus, our results demonstrate that overexpressed, constitutively active PI3 kinase or Akt is capable of protecting cells from apoptosis but do not exclude the possibility that other antiapoptotic signals are also generated by the IGF-I receptor.
Recent reports indicate an important role for ERK1 and ERK2 in protecting differentiated PC12 cells from apoptosis induced by growth factor withdrawal (67) and hematopoietic cells from ceramide-induced apoptosis (14) . For these reasons, we were interested in determining whether these MAP kinases play a role in antiapoptotic signalling by the IGF-I receptor. However, we found that in the system described here, MAP kinase appears to be irrelevant to the induction of or protection from apoptosis. EGF, which is not protective, induced MAP kinase activation which was greater in both magnitude and duration than that induced by IGF-I. Conversely, treatment of Rat-1 cells with PD98059, a specific inhibitor of MEK activation (2), blocked activation of MAP kinase by IGF-I and had no detectable effect on the sensitivity to apoptosis. Thus, ERK activation is neither necessary nor sufficient for protection against UV-induced apoptosis. This finding is in agreement with the conclusions of Creedon et al. (12) and OwenLynch et al. (44) .
We also have examined activation of p38/HOG1 in this system and find no direct correlation between changes in the activity of this so-called stress pathway member of the MAP kinase superfamily and the degree of apoptosis. As with our studies on the role of ERKs, these results contrast with those of Xia et al. (67) but agree with those of Liu et al. (32) .
We do not know why our results differ so dramatically from some of those described for PC12 cells and hematopoietic cells (14, 67) , but it is possible that these earlier results are specific to the cells and inducers of apoptosis which were investigated. For example, the activated MAP kinases are largely nuclear, and their best-characterized substrates are transcription factors. It is not unreasonable to speculate that situations in which MAP kinases regulate the commitment to apoptosis are those in which new gene expression is required for the regulation of apoptosis. By contrast, in the system used here, both the induction of apoptosis by UV and its inhibition by IGF-I could occur in the presence of cycloheximide. We thus suspect that IGF-I-induced activation of PI3 kinase is proximal to a step in activation of the apoptosis effector pathway. We believe that the simplicity of this system will render it more amenable to biochemical and mechanistic analysis.
A cascade of ICE-related proteases appears to be central to apoptotic pathways initiated by TNF and Fas ligand (6, 38) . Transfection of an ICE proenzyme is capable of inducing apoptosis, and the apoptosis can be inhibited by IGF-I (26). We speculate that PI3 kinase, Akt, and/or other effectors regulate proapoptotic proteolytic cascades. Experiments to test this hypothesis are in progress. 
